冷冻自体与供卵的活产及围产结局:HFEA数据库分析
冷冻自体卵较冷冻供卵活产率更低但低出生体重风险更低;冷冻供卵活产率低于新鲜供卵。
要点
- 冷冻自体卵活产率18.0%,低于冷冻供卵30.7%(aOR 0.61)。
- 冷冻自体卵低出生体重5.3%,低于冷冻供卵14.0%(aOR 0.29)。
- 冷冻供卵活产率30.7%,低于新鲜供卵34.7%(aOR 0.69)。
核心结论
- 冷冻自体卵较冷冻供卵活产率更低但低出生体重风险更低,早产无显著差异。
- 冷冻供卵活产率低于新鲜供卵。
- 首周期冷冻供卵与自体冷冻胚胎相比低出生体重更高。
研究设计与样本
- 围产结局仅评估单胎出生。
- 三个临床模型比较冷冻自体卵、冷冻供卵、新鲜供卵及首周期冷冻胚胎移植。
主要发现
- 冷冻自体卵(n=632) vs 冷冻供卵(n=922):活产18.0% vs 30.7%(aOR 0.61, 95%CI 0.43-0.85)。
- 低出生体重5.3% vs 14.0%(aOR 0.29, 95%CI 0.13-0.90),早产9.5% vs 15.7%(aOR 0.56, 95%CI 0.26-1.21)。
- 首周期冷冻供卵(n=917) vs 首周期自体冷冻胚胎(n=326):活产30.1% vs 19.3%(aOR 1.26, 95%CI 0.86-1.83),低出生体重17.7% vs 5.4%(aOR 3.77, 95%CI 1.51-9.43)。
关键数值与推荐
- 早产定义为37周前活产,低出生体重定义为出生体重<2500 g。
- 调整了母亲年龄、移植胚胎数和治疗年代等混杂变量。
临床怎么用
- 咨询计划冷冻自体卵用于生育力保存或社会性卵子冷冻的女性时,应说明冷冻供卵库的结果可能不完全适用。
- 可告知卵子冷冻保存似乎不损害围产结局。
局限性
- 缺乏卵子冷冻指征、冷冻方法(慢速冷冻或玻璃化)及冷冻时年龄。
- 仅报告了37岁前使用自体冷冻卵的女性的亚组分析。
- 因数据集匿名,无法评估累积活产率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Are live birth (LB) and perinatal outcomes affected by the use of frozen own versus frozen donor oocytes? SUMMARY ANSWER: Treatment cycles using frozen own oocytes have a lower LB rate but a lower risk of low birth weight (LBW) as compared with frozen donor oocytes. WHAT IS KNOWN ALREADY: A rising trend of oocyte cryopreservation has been noted internationally in the creation of donor oocyte banks and in freezing own oocytes for later use in settings of fertility preservation and social egg freezing. Published literature on birth outcomes with frozen oocytes has primarily utilised data from donor oocyte banks due to the relative paucity of outcome data from cycles using frozen own oocytes. STUDY DESIGN, SIZE, DURATION: This was a retrospective cohort study utilising the anonymised database of the Human Fertilisation and Embryology Authority, which is the statutory regulator of fertility treatment in the UK. We analysed 988 015 IVF cycles from the Human Fertilisation and Embryology Authority (HFEA) register from 2000 to 2016. Perinatal outcomes were assessed from singleton births only. PARTICIPANTS/MATERIALS, SETTING, METHODS: Three clinical models were used to assess LB and perinatal outcomes: Model 1 compared frozen own oocytes (n = 632) with frozen donor oocytes (n = 922); Model 2 compared frozen donor oocytes (n = 922) with fresh donor oocytes (n = 24 706); Model 3 compared first cycle of fresh embryo transfer from frozen donor oocytes (n = 917) with first cycle of frozen embryo transfer created with own oocytes and no prior fresh transfer (n = 326). Preterm birth (PTB) was defined as LB before 37 weeks and LBW as birth weight <2500 g. Adjustment was performed for confounding variables such as maternal age, number of embryos transferred and decade of treatment. MAIN RESULTS AND THE ROLE OF CHANCE: The LB rate (18.0% versus 30.7%; adjusted odds ratio (aOR) 0.61, 95% CI 0.43-0.85) and the incidence of LBW (5.3% versus 14.0%; aOR 0.29, 95% CI 0.13-0.90) was significantly lower with frozen own oocytes as compared with frozen donor oocytes with no significant difference in PTB (9.5% versus 15.7%; aOR 0.56, 95% CI 0.26-1.21). A lower LB rate was noted in frozen donor oocyte cycles (30.7% versus 34.7%; aOR 0.69, 95% CI 0.59-0.80) when compared with fresh donor oocyte cycles. First cycle frozen donor oocytes did not show any significant difference in LB rate (30.1% versus 19.3%; aOR 1.26, 95% CI 0.86-1.83) or PTB, but a higher incidence of LBW (17.7% versus 5.4%; aOR 3.77, 95% CI 1.51-9.43) as compared with first cycle frozen embryos using own oocytes. LIMITATIONS, REASONS FOR CAUTION: The indication for oocyte freezing, method of freezing used (whether slow-freezing or vitrification) and age at which eggs where frozen were unavailable. We report a subgroup analysis of women using their own frozen oocytes prior to 37 years. Cumulative LB rate could not be assessed due to the anonymous nature of the dataset. WIDER IMPLICATIONS OF THE FINDINGS: Women planning to freeze their own eggs for fertility preservation or social egg freezing need to be counselled that the results from frozen donor egg banks may not completely apply to them. However, they can be reassured that oocyte cryopreservation does not appear to have a deleterious effect on perinatal outcomes. STUDY FUNDING/COMPETING INTEREST(S): No specific funding was sought for the study. The authors have no relevant conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Mascarenhas M, Mehlawat H, Kirubakaran R, et al. Live birth and perinatal outcomes using cryopreserved oocytes: an analysis of the Human Fertilisation and Embryology Authority database from 2000 to 2016 using three clinical models. Hum Reprod. 2021. PMID: 33313698. doi:10.1093/humrep/deaa343
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。